FDA au­tho­rizes ado­les­cent use of Omi­cron-spe­cif­ic boost­ers

Bi­va­lent boost­er shots spe­cif­ic to cur­rent­ly cir­cu­lat­ing Omi­cron strains will soon be avail­able to chil­dren as young as 5 years old.

The FDA has au­tho­rized Pfiz­er and BioN­Tech’s boost­er in chil­dren ages 5 through 11, the com­pa­nies an­nounced on Wednes­day, as well as Mod­er­na’s for­mu­la­tion in kids 6 through 17 years old. Both shots are spe­cif­ic to the Omi­cron BA.4/BA.5 sub­vari­ants, which ac­count for more than 80% of cas­es in the US, ac­cord­ing to Pfiz­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.